Therefore, the purpose of the present study was to correlate the qualitative and quantitative MRI phenotypes of breast cancer (regarding tumor morphology and heterogeneity) and the whole RNA-sequencing data, and thereby to identify imaging surrogates that could be useful to predict clinical outcomes and determine management strategies based on the ER and HER2 status of cancer. This evidence concerns the gene ERBB2 and breast cancer.